baber/WOPTO huggingface dataset:
Patent NZ-507410-A (NZ)
Title: Valve connector for tyre valves with different diameter seals
Inventor: VAN DER BLOM NICOLAAS
IPC: F16K15/20
Filed: 1996-02-02
Abstract: A valve connector (301) for coupling with a multitude of inflation valves of vehicle tyres comprising; a housing (302) that has a coupling hole to couple with an inflation valve, multiple inflation valve positioning means, an activating pin (312) arranged coaxially with the coupling hole to depress the spring operated core pin of an inflation valve, a cylinder (303) having a pressure port connected to the pressure source.  The activating pin (312) is coupled with a piston (304) arranged in the cylinder (303), which is moved between an actuating and non-actuating position by the pressure source and inflation valve position respectively.  There is an airflow path (309,310) from the pressure source, which is either open or closed depending on the relative position of the piston and airflow path outlet (310).
Patent NZ-512721-A (NZ)
Title: Selecting animals for parentally imprinted traits
Inventor: ANDERSSON LEIF
IPC: C12Q1/68
Filed: 1999-12-16
Abstract: A method of selecting animals destined for slaughter having desired genotypic properties (e.g. muscle mass), comprising testing said animal for the presence of a parentally imprinted quantitative trait (QTL).
Patent NZ-512782-A (NZ)
Title: Superconducting power transmission cable
Inventor: ASHWORTH STEPHEN P
IPC: H01B12/14
Filed: 2001-07-05
Abstract: A superconducting power cable includes phase conductors 30 each made up of stacks of subconductors 50, and extending between the ends of the dielectric casing 20 of the cable.  The subconductors each include an array of superconductive material tapes 60 mounted on a steel or hastelloy support 65 and extending from one end of the casing to the other.  The tapes are spaced edge to edge by gaps 67 and the subconductor face-to-face spacings 70 are maintained along the length of the cable.  Coolant is flowed through the spacing channels and the casing may have an outer thermal insulation.
Patent NZ-513158-A (NZ)
Title: End member for a bone fusion implant
Inventor: MESSERLI DOMINIQUE D
IPC: A61B17/58
Filed: 2000-02-03
Abstract: An end member for use with an implant for fusing bone, comprising: a first portion with a longitudinal axis and a top surface for contacting a bone wherein the top surface has a first channel for receiving a surgical instrument, said first channel covering between 20% and 80% of the cross-section of the first section; a second portion coaxial to the longitudinal axis configured and dimensioned to be mounted at the end of the implant; and a shoulder joining the first and second portions and sized to rest on an edge of the implant when the second portion is mounted at the implant.
Patent NZ-516610-A (NZ)
Title: Benzanilides as potassium channel openers
Inventor: MCNAUGHTON-SMITH GRANT ANDREW
IPC: C07D521/00
Filed: 2000-08-04
Abstract: Benzanilide compounds of the formula useful for the treatment of diseases such as central or peripheral nervous system disorders, through the modulation of potassium ion flux through voltage-dependent potassium channels.
Patent NZ-516650-A (NZ)
Title: Coating colour
Inventor: WESTON PHILIP MARK
IPC: D21H19/58
Filed: 2000-07-17
Abstract: A coating colour composition comprising an aqueous dispersion of: a) a pigment, b) a binder, c) a fluorescent whitener, and d) a water-soluble polymer formed from a water-soluble ethylenically unsaturated monomer or monomer blend; wherein the water-soluble polymer consists essentially of: i) 90 to 100 mole % hydrophilic essentially nonionic repeating units, and ii) 0 to 10 mole % anionic repeating units; and has an average molecular weight of between 50,000 and 500,000.
Patent NZ-517348-A (NZ)
Title: Use of a mycobacterial extract in the treatment of inflammatory bowel disease
Inventor: BORODY THOMAS JULIUS
IPC: A61K35/74
Filed: 1998-04-01
Abstract: Use of Regressin, a mycobacterial extract or product for the manufacture of a medicament for the treatment of inflammatory bowel disease.
Patent NZ-519685-A (NZ)
Title: A Bird Repellent
Inventor: DAY TIM
IPC: A01M29/12
Filed: 2002-06-20
Abstract: Disclosed is a bird repellant composition comprising one of the following combinations: (i) anthraquinone and a visual cue, (ii) anthraquinone and d-pulegone, (iii) anthraquinone, a visual cue and d-pulegone, wherein the visual cue is a blue or green dye with a lowered relative reflective wavelength in the range 500 to 700 nm, wherein the combination produces a synergistic effect of repellence to birds. The repellant composition may also be used in a bait composition. Also disclosed is a method of repelling birds from an environment or object comprising applying the above repellant to the environment or object.
Patent NZ-529009-A (NZ)
Title: Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levels
Inventor: MAN HON-WAH
IPC: A61P29/00
Filed: 2000-12-19
Abstract: Substituted 1,3,4-oxadiazoles are described that can reduce levels of TNF-alpha, phosphodiesterase type 4, and NFkappaB. These compounds can be used in pharmaceutical compositions for treating conditions such as endotoxemia, toxic shock syndrome, rheumatoid arthritis, inflammatory bowel disease, cahexia, lupus, adult respiratory disease syndrome, graft versus host disease, celebral malaria, chronic pulmonary inflammatory disease, reperfusion injury, myocardial infarction, stroke, circulatory shock, asthma, inflammation, sepsis, endotoxic shock, hemodynamic shock, post ischemia reperfusion injury, malaria, mycobacterial infection, meningitis, psoriasis and other dermal diseases, congestive heart failure, fibrotic disease cancer tumor growth, angiogenesis, auto immune diseases, AIDS infections, rheumatoid spondylitis osteoarthritis, Crohn's disease, ulcerative colitis, multiple sclerosis, osteoporosis, periodontitis, gingivitis and atopic dermatitis.
Patent NZ-531647-A (NZ)
Title: Glycoconjugate vaccines for use in immune-compromised populations against Staphylococcal and Enterococcal infections
Inventor: FATTOM ALI I
Filed: 2002-09-19
Abstract: Disclosed is the use of Staphylococcal Type 5 and Type 8 and Enterrococcal glycoconjugate vaccines in the manufacture of a medicament preventing or treating bacterial infection in an immune-compromised individual. Such vaccines contain an immunocarrier and a conjugate of a polysaccharide or glycopeptide surface antigen from a clinically-significant bacterial strain. The vaccines can be used for active protection in immune-compromised individuals who are to be subjected to conditions that place them at immediate risk of developing a bacterial infection, as would be the case in the context of a catheterization or a surgical procedure.
Patent NZ-536442-A (NZ)
Title: Amidoacetonitrile compounds and their use as pesticides
Inventor: DUCRAY PIERRE
IPC: A01N39/02
Filed: 2003-06-05
Abstract: Disclosed herein are amidoacetonitrile compounds of formula (I) and the enantiomers thereof, wherein the variables are as defined in the specification. These compounds as active ingredients have advantageous pesticidal properties and they are especially suitable for controlling parasites on warm-blooded animals.
Patent NZ-538488-A (NZ)
Title: Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
Inventor: SURLERAUX DOMINIQUE LOUIS NEST
IPC: A61K31/4439
Filed: 2003-08-04
Abstract: Disclosed is a use of 2-amino-benzothiazoles, having the formula (I), a N-oxide, salt, stereoisomeric form, racemic mixture, prodrug or ester thereof, wherein R1 is hexahydrofuro[2,3-b]furanyl, tetrahydrofuranyl, oxazolyl, thiazolyl, pyridinyl, or phenyl optionally substituted with one or more substituents independently selected from C1-6-alkyl, hydroxy, amino, halogen, aminoC1-4-alkyl and mono-or di(C1-4alkyl)amino; R2 is hydrogen or C1-6alkyl; L is a direct bond, -O-, C1-6alkanediyl-O- or -O-C1-6alkanediyl; R3 is phenylC1-4alkyl; R4 is C1-6alkyl; R5 is hydrogen or C1-6alkyl; R6 is hydrogen or C1-6alkyl; in the manufacture of a medicament useful for inhibiting mutant HIV protease in a mammal infected with said mutant HIV protease. The disclosure also relates to specific 2-amino-benzothiazole compounds of formula (I).
Patent NZ-539581-A (NZ)
Title: Hormone replacement therapy method using at least one estrogen and at least one gestagen and its administration form
Inventor: KULMANN HERMANN
IPC: A61P5/30
Filed: 2002-01-08
Abstract: Use of an estrogen (E) in combination with a gestagen (G) for the manufacture of an administration form for hormone replacement therapy comprising daily dosage units for oral administration, wherein the daily dosages for the hormone replacement therapy, which may be administered during the perimenopause, during the transition phase or during the postmenopause are as defined in the specification.
Patent NZ-540220-A (NZ)
Title: Multilayer polymeric film with low blocking and high slip properties for packaging applications
Inventor: MCALLISTER LARRY B
Filed: 2003-12-15
Abstract: Disclosed herein is a multilayer polymeric film with low blocking and high slip properties for use in packaging applications, wherein the film comprises: (a) a first and second outer layer each comprising a polymer; (b) a core layer comprising a polymer; and (c) a first and second substrate layer each comprising a polymer, the first and second substrate layers disposed between the core layer and the first and second outer layers respectively ; wherein each of: (i) the first substrate layer, (ii) the second substrate layer, (iii) the first outer layer, and (iv) the second outer layer, comprises a primary fatty amidic wax; wherein the first outer layer comprises primary fatty amidic wax, the amidic wax present in an amount of 1% to 50% of the amount of primary fatty amidic wax in the first substrate layer; and the second outer layer comprises primary fatty amidic wax in an amount of 1% to 50% of the amount of primary fatty amidic wax in the second substrate layer; and wherein at least one of: (i) the first and second outer layers, and (ii) the first and second substrate layers comprises a transition metal salt of stearic acid, or ester of stearic acid.
Patent NZ-541455-A (NZ)
Title: Oligosaccharide derivative
Inventor: HONDA TAKESHI
IPC: A61K31/7032
Filed: 2004-01-29
Abstract: Disclosed is a compound represented by the general formula I, highly active and safe the compound is useful as a therapeutic agent and/or preventive agent for diabetes etc.
Patent NZ-542167-A (NZ)
Title: Mitochondrially targeted antioxidants
Inventor: MURPHY MICHAEL PATRICK
Filed: 1998-11-25
Abstract: Disclosed is a mitochondrially-targeted antioxidant compound comprising formula (I) wherein X is a linking group, Z is an anion and R is an antioxidant moiety, wherein the mitochondrially-targeted antioxidant is capable of being transported through the mitochondrial membrane and accumulated within the mitochondria or intact cells.
Patent NZ-563273-A (NZ)
Title: Cathepsin S antibody
Inventor: SCOTT CHRISTOPHER
IPC: C12N15/13
Filed: 2006-04-10
Abstract: Provided is the use of an antibody or fragment thereof or a nucleic acid encoding said antibody or fragment thereof in the preparation of a medicament for the treatment of an angiogenesis-mediated disorder or condition wherein the antibody or fragment thereof binds cathepsin S and inhibits its proteolytic activity. Further provided is an antibody with specified sequence that binds cathepsin S and inhibits its proteolytic activity as well as corresponding nucleic acids and methods of producing such antibodies.
Patent NZ-564190-A (NZ)
Title: Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
Inventor: HARTMANN DIDIER
IPC: A24D3/04
Filed: 2006-06-21
Abstract: A smoking device, a breakable capsule, and a process for manufacturing breakable capsules is disclosed. The smoking device comprises a recipient including or able to receive tobacco, a filter element connected to the recipient, and a breakable capsule. The filter comprises at least one breakable capsule where the capsule comprises a shell and a core. The capsule has an initial crush strength Ci from 0.5 to 2.5 kp and keeps a crush strength Cf from 0.5 to 2.5 kp, and presents a deformation of less than two thirds of its diameter prior to rupture, after having been submitted to a smoking test.
Patent NZ-566025-A (NZ)
Title: A roll of wrapping blanks where each individual blank has a continuous part and a breathable part
Inventor: DERSCHEID DANIEL ERIC
IPC: A01F15/07
Filed: 2005-11-29
Abstract: A roll (100) of material for baling agricultural materials is disclosed. The roll (100) consists of a plurality of individual wrapping portions (110) connected together, end to end. Each wrapping portion (110) has a fastener (150), such as one part of a hook and loop fastener, to secure the portion (110) around a bale when connected to the other half on the opposite side of the portion material. To enable moisture to leave the bale when wrapped, some part or parts of the portion (110) are of a breathable material (130). To enable protection from rain and ground moisture some part or parts of the portion (130) are of a continuous material (120), such as a plastic film.
Patent NZ-569011-A (NZ)
Title: Aryl substituted sulfonic acid amides with medicinal effects due to interaction with the glucocorticoid receptor
Inventor: HAMILTON NIALL MORTON
IPC: A61K31/18
Filed: 2006-12-18
Abstract: Disclosed are compounds of formula I wherein X is a carbon or nitrogen atom, Ar is a phenyl or heteroaromatic ring and the remaining substituents are as defined in the specification, or a pharmaceutically suitable acid addition salt thereof, their interaction with glucocorticoid steroid receptors and their use in treating stress related disorders, depression and anxiety.
Patent NZ-572022-A (NZ)
Title: Resectoscopic device and method
Inventor: LARSEN DANE M
IPC: A61B17/94
Filed: 2007-04-05
Abstract: A surgical resection instrument includes a longitudinal shaft 1300 with an enclosed, blunt distal end 1302 and a proximate end, an internal fluid flow path 206 including a portion dimensioned to allow passage of tissue resected from a working area 812 within the shaft towards the proximate end, and an externalizable fluid flow path 818. The working area is defined by a port in a sidewall of the shaft. A switch 820 is coupled to the internal flow path and the externalizable fluid flow path and can be actuated to control infusion fluid flow 204 into the internal flow path and the externalizable fluid flow path.
Patent NZ-576357-A (NZ)
Title: Salts and crystal forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile
Inventor: STOWASSER FRANK
IPC: A61K31/4745
Filed: 2007-11-16
Abstract: Disclosed are forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5- c]quinolin-1-yl)-phenyl]-propionitrile (compound I, see below), its hydrates and solvates, its salts and hydrates and solvates of its salts, certain processes for their preparation, pharmaceutical compositions containing these solid forms, and their use in diagnostic methods or, preferably, for the therapeutic treatment of warm-blooded animals, especially humans, and their use as an intermediate or for the preparation of pharmaceutical preparations for use in diagnostic methods or, preferably, for the therapeutic treatment of warm-blooded animals, especially humans.
Patent NZ-577740-A (NZ)
Title: 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
Inventor: CHEN HUANMING
IPC: A61K31/165
Filed: 2007-11-28
Abstract: Disclosed are diamino bicyclic retigabine analogues of formula (I), salts, solvates and esters thereof, and methods for their preparation. Specific examples of compounds of formula (I) include: N-(5-(4-fluorophenylamino)-1,3-dimethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-3,3-dimethylbutanamide; N-(1-(4-fluorophenylamino)-4,6-dimethyl-2,3-dihydro-1H-inden-5-yl)-3,3-dimethylbutanamide; and Ethyl 1-(4-fluorophenylamino)-2,3-dihydro-1H-inden-5-yl-carbamate. The compounds of formula (I) modulate potassium channels and are useful for treating hyperexcitability of the nervous system such as neuropathic and chronic pain, bipolar disorder, migraine, epilepsy, a seizure or a disorder characterized by a seizure.
Patent NZ-582719-A (NZ)
Title: Calibration device for calibrating weight measurement devices
Inventor: CAFFERTY ALEXANDER MCDERMAID
IPC: G01G23/01
Filed: 2010-01-19
Abstract: Disclosed is a calibration device for calibrating weight measurement apparatuses. The calibration device includes a base having first and second ends and a lever having first and second ends, where the first end of the lever is pivotally attached to the base at or near the first end of the base. The calibration device also includes an adjustment member in the form of a shaft having first and second ends, where the first end of the adjustment member is pivotally attached to the base at or near the second end of the base. The device further includes an actuation member for rotating the adjustment member and a load cell in communication with the lever to sense vertical movement of the lever. The load cell is connected to a digital display for displaying a load calculated by the load cell. The device also includes a connector for attaching a load. A portion of the adjustment member shaft is threaded and the lever includes a coupling at or near the second end of the lever. The coupling includes an aperture having a threaded interior for engagement with the threaded portion of the adjustment member such that rotation of the adjustment member causes the lever to move along the adjustment member shaft. Also disclosed is an anchor member for attaching the calibration device to a mounting surface.
Patent NZ-586408-A (NZ)
Title: Breed-specific haplotypes for polled (without horns) phenotypes in cattle
Inventor: GILL CLARE A
IPC: C12Q1/68
Filed: 2008-12-18
Abstract: Disclosed is a method for identifying a bovine animal having Polled phenotype, as compared to the general population of bovine animals, comprising: (a) obtaining a biological sample from said bovine animal; (b) subjecting the sample to nucleotide sequence analysis to obtain sufficient nucleotide sequence information to provide the identity of the nucleotides at positions corresponding to the following SEQ ID NO:43 positions: 1356048, 1872077, 1872200, 2101528, 2214142, 2220054, 2220178, 2225310, 2288436, 2332892, 2333140, 2338338, 2816109, 2816370, 1013610, 1352705, 1352905, 1431709, 1438531, 1731905, 2128551, 2640799, 2648129,2650867, 2651006, 2657651, 2676311, and 2820224; (c) detecting in said animal a haplotype of the alleles present at at least three nucleotides or a genotype of the alleles present at at least five nucleotides, wherein the at least three or at least five nucleotides in the haplotype or the genotype are nucleotides detected at the positions analyzed in part (b), wherein the said haplotype or said genotype is sufficient to conclude that the animal will exhibit the Polled phenotype; (d) identifying the animal as having the Polled phenotype based on the presence of the haplotype comprised of at least three of said positions or the genotype comprised of at least five positions, wherein the haplotype comprises at least three or the genotype at least five of the following alleles: 1356048 (G), 1872077 (G), 1872200 (C), 2101528 (C), 2214142 (A), 2220054 (C), 2220178 (A), 2225310 (T), 2288436 (A), 2332892 (T), 2333140 (A), 2338338 (T), 2816109 (G), 2816370 (G), 1013610 (C), 1352705 (A), 1352905 (G), 1431709 (A), 1438531 (C), 1731905 (G), 2128551 (C), 2640799 (A), 2648129 (C), 2650867 (A), 2651006 (T), 2657651 (C), 2676311 (C), and 2820224 (G).
Patent NZ-586614-A (NZ)
Title: Collapsible Tennis coaching cart/trolley
Inventor: PATERSON MAREEA
IPC: B62B3/00
Filed: 2010-07-14
Abstract: A collapsible tennis coaching cart for on court coaching use during tennis lessons and for storing, transporting tennis balls or equipment is disclosed. The cart includes a main frame comprising a large main frame, a small main frame and means for supporting a removable top basket and a removable bottom basket. The top basket supports an adjustable and removable divider tray, features a branded metal plate, and has the capacity to hold 240 tennis balls. The bottom basket supports a movable accessories holder that may have various stored positions on the cart, features a clip system, and has the capacity to hold 150 Tennis balls. The large main frame is provided with an easy clean plastic grip.
Patent NZ-588472-A (NZ)
Title: Wire tension sensor with indicator
Inventor: MALINS CRAIG DAVID
IPC: E04H17/00
Filed: 2011-02-25
Abstract: Disclosed is a wire fence accessory (1) to measure tension of a wire. The accessory includes: a connector (11) to secure the accessory to a post of a wire fence; a tension sensor to measure tension in a wire and output a signal; and an indicator (5a, 5b, 5c) to output, at the accessory, an indication of the tension in the wire corresponding to the signal.
Patent NZ-590154-A (NZ)
Title: Isoquinolinone derivatives as nk3 antagonists
Inventor: KHANZHIN NIKOLAY
IPC: C07D401/04
Filed: 2009-06-19
Abstract: Disclosed is an acrylamide substituted isoquinolinone compound of formula (I) where y is a hetero aromatic moiety having 5-6 ring atoms and the remaining substituents are as disclosed in the description. Also disclosed is a pharmaceutical composition comprising a compound of formula (I).
Patent NZ-590550-A (NZ)
Title: Inhibitors of Apoptosis (IAP) for treating cancer
Inventor: DUDLEY DANETTE
IPC: A61K31/4025
Filed: 2009-07-23
Abstract: ABSTRACT - 590550 Disclosed herein is a compound of formula (I) and a salt or solvate thereof, wherein the variables are defined in the specification. These compounds are inhibitors of apoptosis (IAP) and are suitable for treating a disease or condition associated with the overexpression of an IAP protein, particularly for the treatment of cancer.
Patent NZ-591440-A (NZ)
Title: Wave-powered energy generation apparatus with a plurality of pontoons
Inventor: MORGAN MATTHEW
IPC: E02B9/08
Filed: 2009-08-10
Abstract: Disclosed is a wave-powered energy generation apparatus (10). The apparatus has a plurality of pontoons (12.1, 12.2, 12.3) articulatingly connected to each other. At least one of the platoons (12.2) is substantially curved. The apparatus has a mooring point (19) for mooring the apparatus in a body of water. The apparatus also has a power generation system which is powered by articulating movement between the pontoons.
Patent NZ-592808-A (NZ)
Title: Determining immunoglobulins in oral secretions of neonatal ungulates
Inventor: SMITH NATHAN L
IPC: G01N33/48
Filed: 2009-11-02
Abstract: A method for determining a failure in passive transfer of immunity to a neonatal ungulate. The method comprises obtaining oral secretions from the neonatal ungulate and measuring the amount of immunoglobulins in the oral secretions relative to a control sample. The neonatal ungulate can be bovine, in particular Bos Taurus or Bos primigenius. Also disclosed is a method of treating failure in passive transfer of immunity in a neonatal ungulate by administering a composition comprising immunoglobulins.
Patent NZ-594036-A (NZ)
Title: Substituted bicyclic imidazole derivatives as gamma secretase modulators
Inventor: GIJSEN HENRICUS JACOBUS MARIA
IPC: A61K31/4188
Filed: 2009-12-16
Abstract: Disclosed herein are substituted imidazo[1,2a]pyridine derivatives of formula (I), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds as uses thereof. Said compounds are useful as Gamma Secretase Modulators (GSM) and as such are therefore useful in the treatment of prevention of a disease or condition such as Alzheimer's disease, traumatic brain injury, mild cognitive impairment, senility, dementia, dementia with Lewy bodies, cerebral amyloid angiopathy, multi-infarct dementia, Down's syndrome, dementia associated with Parkinson's disease and dementia associated with beta-amyloid.